Filip Bergquist
Sahlgrenska University Hospital(SE)Sahlgrenska University Hospital(SE)University of Gothenburg(SE)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders, Neurotransmitter Receptor Influence on Behavior, Muscle activation and electromyography studies
Most-Cited Works
- → Transplantation of Human Embryonic Stem Cell-Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation(2006)438 cited
- → The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors(2012)391 cited
- → GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality(2015)155 cited
- → The Stomach-Derived Hormone Ghrelin Increases Impulsive Behavior(2015)102 cited
- → Effects of Stochastic Vestibular Galvanic Stimulation and LDOPA on Balance and Motor Symptoms in Patients With Parkinson's Disease(2014)96 cited
- → Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study